Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Perspective, J Virol Antivir Res Vol: 10 Issue: 1
Antiviral Techniques
Ramya Chiyyadri *
Department of pharmacy, KIT’s college of Pharmaceutics, Guntur, Andhra Pradesh, India
*Corresponding author
Department of pharmacy, KIT’s college of Pharmaceutics, Guntur, Andhra Pradesh, India
E-mail: ramyachiyyadri0045@gmail.com
Received: January 08, 2019 Accepted: January 22, 2020 Published: January 29, 2021
Citation: Chiyyadri R (2021) Antiviral Techniques. J Virol Antivir Res 10:1 208
Abstract
In Antiviral techniques and conventions experienced scientists narrate in an easily followed initializing their state of the art approaches for evaluating antiviral combinations. The assays related include systems for scrutinizing drugs used against herpes viruses, hepatitis viruses, human immunodeficiency viruses, human papillomaviruses and influenza viruses. These well tested methods range from cellular note to some of the most up to date microscopic speaks for identifying compounds that are animated against the viral enzymes and the development of viral resistance opposition to drugs currently in use. The detailed protocols also considered possible pitfalls and ways to overcome them. Timely and extensive, antiviral methods and protocols offers today's researchers in academia, clinical departments and the pharmaceutical industry the strong, reproducible, and novel methods needed to evaluate compounds successful against both acute and chronic infections.
Keywords: Antiviral Techniques; Antiviral drugs
Introduction
Antiviral drugs are prescription medicines i.e. pills, liquid, an inhaled powder and an intravenous solution bottles that fight against viruses in the body. Key Points about antiviral drugs: Able to enter the cells infected with virus, Interfere with viral nucleic acid synthesis or regulation Some agent interfere with virus ability to bind with cell, one agents stimulate the body's immune system. Mechanism of action in combination or single action inhibits the viral attachment; prevent genetic copying of virus, Prevent viral protein production, vital for reproduction in the virus. Unlike antibiotics, which commonly have a broad spectrum of activity and the antiviral compounds are generally highly species specific and for this reason antiviral researchers tend to expertizes in working with a single virus individuals.
Hence one of the most beneficial aspects of the present volume is to expose those working with one virus to the problems and solutions of those working with another. Such cross-fertilization of ideas can only be of useful to all concerned. Perhaps this virusspecific approach has led to one outstanding oversight in compiling the book since generic approaches to combating virus infections, such as the use of interferon or antisense oligonucleotides are immensely ignored.
Discussion
Retroviruses are a kind of virus in the viral family known as Retroviridae. The antiviral drug agents are target diverse group of viruses such as herpes, hepatitis, and influenza viruses. Whereas antiretroviral are the drugs that are utilised to fight retrovirus contaminations which mainly include HIV. Different classes of antiretroviral drugs act on contrasting stages of the HIV life cycle. The broadcasting of antivirals is the product of a our newly acquired knowledge of the genetic and molecular justification of organisms letting people superior appreciation in the structure and function of viruses, the major advances in the techniques for finding new drugs and the pressure placed on the medical profession to deal with the human immunodeficiency virus HIV, the cause of acquired immunodeficiency syndrome AIDS.
Conclusion
All the available information suggests that the need for effective antiviral drugs will continue to grow. International Medical Press PS Jones seen that the techniques used to produce therapeutic agents have evolved continuously. This process is set to continue. The techniques of high through put screening and structure-based drug representation will be enhanced by high throughput chemistry and coupled with more rapid preclinical evaluation. As a result of these strategies people can expect the rapid improvement of many novel antiviral agents over the upcoming decade..
